{"entity":"bristol-myers-squibb","id":"ent_bristol-myers-squibb","name":"Bristol-Myers Squibb","from":"2025-11-09","to":"2026-11-09","page":"https://asof.is/record/bristol-myers-squibb/diff?from=2025-11-09&to=2026-11-09","summary":"Between 2025-11-09 and 2026-11-09, Bristol-Myers Squibb's record changed in 17 facts: 3 replaced (net income -$8.95 billion → $7.05 billion; research and development $11.16 billion → $9.95 billion; revenue $48.3 billion → $48.19 billion), 7 added, 7 ended; 15 unchanged.","counts":{"changed":17,"added":7,"ended":7,"replaced":3,"unchanged":15,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"cash_and_equivalents","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_net_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_research_and_development","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_revenue","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"shares_outstanding","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_assets","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_equity","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"research_and_development","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"ceo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cfo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"chair","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"quarterly_operating_income","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":2},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"x_username","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[{"id":"clm_D7A2CC833948","predicate":"cash_and_equivalents","value":"9,574,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 9,574,000,000 United States dollar\", as of 2026-09-30. Claim clm_D7A2CC833948, https://asof.is/claim/clm_D7A2CC833948, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_D7A2CC833948","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-29"}},{"id":"clm_247D46C4A3C2","predicate":"quarterly_net_income","value":"2,162,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,162,000,000 United States dollar\", as of 2026-09-30. Claim clm_247D46C4A3C2, https://asof.is/claim/clm_247D46C4A3C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_247D46C4A3C2","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-29"}},{"id":"clm_F9CEFB4CA8DE","predicate":"quarterly_research_and_development","value":"2,365,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,365,000,000 United States dollar\", as of 2026-09-30. Claim clm_F9CEFB4CA8DE, https://asof.is/claim/clm_F9CEFB4CA8DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_F9CEFB4CA8DE","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-10-29"}},{"id":"clm_41E4C7C8DCE2","predicate":"quarterly_revenue","value":"13,069,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 13,069,000,000 United States dollar\", as of 2026-09-30. Claim clm_41E4C7C8DCE2, https://asof.is/claim/clm_41E4C7C8DCE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_41E4C7C8DCE2","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-10-29"}},{"id":"clm_434253DF3386","predicate":"shares_outstanding","value":"2,044,085,831 shares","valid_from":"2026-10-21","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,044,085,831 shares\", as of 2026-10-21. Claim clm_434253DF3386, https://asof.is/claim/clm_434253DF3386, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_434253DF3386","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-29"}},{"id":"clm_ABE255E98610","predicate":"total_assets","value":"88,772,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 88,772,000,000 United States dollar\", as of 2026-09-30. Claim clm_ABE255E98610, https://asof.is/claim/clm_ABE255E98610, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_ABE255E98610","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-29"}},{"id":"clm_724BB1A9B7DC","predicate":"total_equity","value":"23,404,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 23,404,000,000 United States dollar\", as of 2026-09-30. Claim clm_724BB1A9B7DC, https://asof.is/claim/clm_724BB1A9B7DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm.","url":"https://asof.is/claim/clm_724BB1A9B7DC","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/0000014272-26-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-29T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-29"}}],"ended":[{"id":"clm_8F913554EE54","predicate":"cash_and_equivalents","value":"15,726,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb cash and equivalents: 15,726,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_8F913554EE54, https://asof.is/claim/clm_8F913554EE54, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_8F913554EE54","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_71B9DA11CD2A","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-30"}},{"id":"clm_B6387AF1FB92","predicate":"quarterly_net_income","value":"2,201,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly net income: 2,201,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_B6387AF1FB92, https://asof.is/claim/clm_B6387AF1FB92, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_B6387AF1FB92","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_59B16D5CFE58","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-30"}},{"id":"clm_F60212FAE72C","predicate":"quarterly_research_and_development","value":"2,528,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly research and development: 2,528,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_F60212FAE72C, https://asof.is/claim/clm_F60212FAE72C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_F60212FAE72C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_66E70FD09231","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-10-30"}},{"id":"clm_BB784B853512","predicate":"quarterly_revenue","value":"12,222,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb quarterly revenue: 12,222,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_BB784B853512, https://asof.is/claim/clm_BB784B853512, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_BB784B853512","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_3BBDC1786FBC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-30"}},{"id":"clm_5DF65CC84443","predicate":"shares_outstanding","value":"2,035,753,027 shares","valid_from":"2025-10-23","valid_to":"2026-02-04","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb shares outstanding: 2,035,753,027 shares\", as of 2025-10-23 (until 2026-02-04). Claim clm_5DF65CC84443, https://asof.is/claim/clm_5DF65CC84443, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_5DF65CC84443","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_7BDDFBA6A82F","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-30"}},{"id":"clm_B080F3CCA436","predicate":"total_assets","value":"96,889,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total assets: 96,889,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_B080F3CCA436, https://asof.is/claim/clm_B080F3CCA436, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_B080F3CCA436","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_16735433DCF9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-30"}},{"id":"clm_3AA608585C53","predicate":"total_equity","value":"18,552,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb total equity: 18,552,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_3AA608585C53, https://asof.is/claim/clm_3AA608585C53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm.","url":"https://asof.is/claim/clm_3AA608585C53","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_D808E9CABB64","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/0000014272-25-000149-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-30"}}],"replaced":[{"predicate":"net_income","from":{"id":"clm_93176D9F8458","predicate":"net_income","value":"-8,948,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: -8,948,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_93176D9F8458, https://asof.is/claim/clm_93176D9F8458, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_93176D9F8458","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_52D44073C808","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_52D44073C808","predicate":"net_income","value":"7,054,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb net income: 7,054,000,000 United States dollar\", as of 2025-12-31. Claim clm_52D44073C808, https://asof.is/claim/clm_52D44073C808, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_52D44073C808","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"research_and_development","from":{"id":"clm_CC290D20ACB7","predicate":"research_and_development","value":"11,159,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 11,159,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_CC290D20ACB7, https://asof.is/claim/clm_CC290D20ACB7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_CC290D20ACB7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D1D9926921B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_1D1D9926921B","predicate":"research_and_development","value":"9,951,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb research and development: 9,951,000,000 United States dollar\", as of 2025-12-31. Claim clm_1D1D9926921B, https://asof.is/claim/clm_1D1D9926921B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_1D1D9926921B","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"revenue","from":{"id":"clm_78596CC18E60","predicate":"revenue","value":"48,300,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 48,300,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_78596CC18E60, https://asof.is/claim/clm_78596CC18E60, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm.","url":"https://asof.is/claim/clm_78596CC18E60","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BB9F55DFC7A5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/0000014272-25-000039-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_BB9F55DFC7A5","predicate":"revenue","value":"48,194,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Bristol-Myers Squibb revenue: 48,194,000,000 United States dollar\", as of 2025-12-31. Claim clm_BB9F55DFC7A5, https://asof.is/claim/clm_BB9F55DFC7A5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm.","url":"https://asof.is/claim/clm_BB9F55DFC7A5","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-11"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}